NCT07084155 Final Prototype Refinement of Adaptive Cell Phone Support
| NCT ID | NCT07084155 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital Los Angeles |
| Condition | Medication Adherence |
| Study Type | INTERVENTIONAL |
| Enrollment | 35 participants |
| Start Date | 2026-03-25 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 35 participants in total. It began in 2026-03-25 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this feasibility pilot trial is to finalize the design of a mobile health intervention for promoting medication adherence in a population of adolescents and young adults with chronic health conditions. The main question\[s\] it aims to answer are: 1. Is the final version of the intervention sufficiently feasible, usable, and acceptable for evaluation in a randomized clinical trial? 2. Do participants show improvements in medication adherence during their field testing of the intervention?
Eligibility Criteria
Inclusion Criteria: * Children's Hospital Los Angeles patient * between 15-20 years old at enrollment * taking at least one oral medication per day for a chronic health condition * English speaking * demonstrating sufficient cognitive capacity to engage in the assent/consent process and study procedures There is no exclusion criteria.
Contact & Investigator
Caitlin Sayegh, PhD
PRINCIPAL INVESTIGATOR
Children's Hospital Los Angeles
Frequently Asked Questions
Who can join the NCT07084155 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 20 Years, studying Medication Adherence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07084155 currently recruiting?
Yes, NCT07084155 is actively recruiting participants. Contact the research team at cssayegh@chla.usc.edu for enrollment information.
Where is the NCT07084155 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT07084155 clinical trial?
NCT07084155 is sponsored by Children's Hospital Los Angeles. The principal investigator is Caitlin Sayegh, PhD at Children's Hospital Los Angeles. The trial plans to enroll 35 participants.